Literature DB >> 31988015

Angelica sinensis extract protects against ischemia-reperfusion injury in the hippocampus by activating p38 MAPK-mediated p90RSK/p-Bad and p90RSK/CREB/BDNF signaling after transient global cerebral ischemia in rats.

Chin-Yi Cheng1, Shung-Te Kao2, Yu-Chen Lee3.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Angelica sinensis (Oliv.) Diels, commonly known as Dang Gui (DG), is one of the most popular traditional Chinese herbal medicines for the treatment of stroke. However, the effects of DG on transient global cerebral ischemia (GCI) and its precise mechanisms remain unclear. AIM OF THE STUDY: This study aimed to investigate the effects of the DG extract on ischemia-reperfusion (I/R) injury in the hippocampus 7 d after transient GCI and to identify the potential mitogen-activated protein kinase (MAPK)-related signaling pathway in the hippocampus involved in the effects.
MATERIALS AND METHODS: Rats were intragastrically administered DG at doses of 0.25 g/kg (DG-0.25g), 0.5 g/kg (DG-0.5g), or 1 g/kg (DG-1g) 1, 3, and 5 d after GCI.
RESULTS: DG-0.5g and DG-1g treatments effectively promoted hippocampal cornu ammonis 1 (CA1) neuronal survival. DG-0.5g and DG-1g treatments markedly increased phospho-p38 MAPK (p-p38 MAPK), phospho-90-kDa ribosomal S6 kinase (p-p90RSK), cytosolic and mitochondrial phospho-Bad (p-Bad), phospho-cAMP response element-binding protein (p-CREB), brain-derived neurotrophic factor (BDNF), and p-CREB/BDNF expression; decreased 4-hydroxy-2-nonenal, cytochrome c (Cytc), and cleaved caspase-3 expression, and inhibited apoptosis in the hippocampal CA1 region. Pretreatment with a specific inhibitor of p38 MAPK, SB203580, completely blocked the effects of DG-1g on the expression of the aforementioned proteins.
CONCLUSIONS: DG-0.5g and DG-1g treatments exerted neuroprotective effects on I/R injury by activating p38 MAPK-mediated p90RSK/p-Bad-induced anti-apoptotic-Cytc/caspase-3-related and p90RSK/CREB/BDNF survival signaling in the hippocampus 7 d after transient GCI.
Copyright © 2020 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  90-kDa ribosomal S6 kinase; Angelica sinensis; Brain-derived neurotrophic factor; Global cerebral ischemia; Phospho-Bad; p38 mitogen-activated protein kinase

Year:  2020        PMID: 31988015     DOI: 10.1016/j.jep.2020.112612

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  11 in total

1.  Neuroprotective Properties of Minocycline Against Methylphenidate-Induced Neurodegeneration: Possible Role of CREB/BDNF and Akt/GSK3 Signaling Pathways in Rat Hippocampus.

Authors:  Majid Motaghinejad; Manijeh Motevalian
Journal:  Neurotox Res       Date:  2022-04-21       Impact factor: 3.911

Review 2.  A Review of Traditional Chinese Medicine, Buyang Huanwu Decoction for the Treatment of Cerebral Small Vessel Disease.

Authors:  Liying Sun; Xuhui Ye; Linlin Wang; Junping Yu; Yan Wu; Minpeng Wang; Lihua Dai
Journal:  Front Neurosci       Date:  2022-06-29       Impact factor: 5.152

3.  Effect of prior exposure to enriched environment on cellular apoptosis after experimental stroke.

Authors:  Xiuping Chen; Xin Zhang
Journal:  Mol Biol Rep       Date:  2022-05-04       Impact factor: 2.742

4.  Activation of GPR40 induces hypothalamic neurogenesis through p38- and BDNF-dependent mechanisms.

Authors:  Daiane F Engel; Vanessa C D Bobbo; Carina S Solon; Guilherme A Nogueira; Alexandre Moura-Assis; Natalia F Mendes; Ariane M Zanesco; Athanasios Papangelis; Trond Ulven; Licio A Velloso
Journal:  Sci Rep       Date:  2020-07-06       Impact factor: 4.379

5.  Continuous administration of a p38α inhibitor during the subacute phase after transient ischemia-induced stroke in the rat promotes dose-dependent functional recovery accompanied by increase in brain BDNF protein level.

Authors:  John J Alam; Michael Krakovsky; Ursula Germann; Aharon Levy
Journal:  PLoS One       Date:  2020-12-04       Impact factor: 3.240

Review 6.  Changes in Hippocampal Plasticity in Depression and Therapeutic Approaches Influencing These Changes.

Authors:  Wenbo Xu; Xiaoxiao Yao; Fangyi Zhao; Haisheng Zhao; Ziqian Cheng; Wei Yang; Ranji Cui; Songbai Xu; Bingjin Li
Journal:  Neural Plast       Date:  2020-11-26       Impact factor: 3.599

7.  ASMq protects against early burn wound progression in rats by alleviating oxidative stress and secondary mitochondria‑associated apoptosis via the Erk/p90RSK/Bad pathway.

Authors:  Hanlei Zhou; Quan Fang; Nan Li; Meirong Yu; Hongming Chen; Songxue Guo
Journal:  Mol Med Rep       Date:  2021-03-24       Impact factor: 2.952

8.  GSK-126 Protects CA1 Neurons from H3K27me3-Mediated Apoptosis in Cerebral Ischemia.

Authors:  Zhongcheng Wang; Yaxin Su; Lei Zhang; Ting Lan; Li Li; Suhua Qi
Journal:  Mol Neurobiol       Date:  2022-01-29       Impact factor: 5.682

9.  Prediction and validation of potential molecular targets for the combination of Astragalus membranaceus and Angelica sinensis in the treatment of atherosclerosis based on network pharmacology.

Authors:  Tianyue Wang; Yaqiong Zhou; Kaina Wang; Xinyu Jiang; Jingbo Wang; Jing Chen
Journal:  Medicine (Baltimore)       Date:  2022-07-01       Impact factor: 1.817

Review 10.  Therapeutic targets by traditional Chinese medicine for ischemia-reperfusion injury induced apoptosis on cardiovascular and cerebrovascular diseases.

Authors:  Xiuli Cheng; Jin Hu; Xiaofeng Liu; Jonnea Japhet Tibenda; Xiaobo Wang; Qipeng Zhao
Journal:  Front Pharmacol       Date:  2022-08-19       Impact factor: 5.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.